SNG: Dr. Sulaiman Al Habib logs over $293mln profits in H1-25; dividends unveiled

Staff Writer

Riyadh: The net profits after tax of Dr. Sulaiman Al Habib Medical Services Group increased by 3.80% to SAR 1.14 billion in the first half (H1) of 2025 from SAR 1.10 billion in H1-24.

Revenues surged by 28.40% year-on-year (YoY) to SAR 6.54 billion as of 30 June 2025 from SAR 5.09 billion, according to the financial statements.

Earnings per share (EPS) amounted to SAR 3.28 in H1-25, versus SAR 3.16 in H1-24.

Results for Q2-25

In the second quarter (Q2) of 2025, the net profits witnessed a 6.48%% YoY rise to SAR 591.02 million, compared to SAR 555.03 million.

The revenues climbed by 31.50% to SAR 3.38 billion in Q2-25 from SAR 2.57 billion a year earlier.

Quarterly, the Q2-25 net profits increased by 6.10% from SAR 557.01 million in Q1-25, while revenues grew by 7.17% from SAR 3.15 billion.

Cash Dividends

The medical group announced cash dividends totaling SAR 416.50 million to 350 million eligible shares for Q2-25. The board approved the distribution of SAR 1.19 per share, representing 11.90% of the share nominal value.

Eligibility and payment dates for the dividends will be 31 July and 18 August, respectively.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.